Diagnosing Sezary syndrome (SS) on clinicopathological grounds alone is far
from straightforward, particularly in the early stages of the disease. Aty
pical lymphocytes may be seen in the peripheral blood of patients with reac
tive forms of erythroderma, so additional criteria are needed to establish
the diagnosis of a T-cell leukemia/lymphoma. A wide variety of confirmatory
tests have been proposed in the literature, but there has been no systemat
ic attempt to compare the specificity and sensitivity of these different me
thods. Recent data indicate that T-cell receptor (TCR) gene analysis is the
most useful test currently available and that methods based on polymerase
chain reaction are more sensitive than Southern blot analysis. We propose t
hat the diagnostic criteria for SS should include erythroderma, atypical ci
rculating mononuclear cells, and evidence of a clonal T-cell population in
the peripheral blood. Clonality can be established with certainty by cytoge
netic or TCR gene analysis, but only the latter is sufficiently sensitive t
o be of value in routine diagnosis. Immunophenotypic data showing an expand
ed CD4(+)/CD7(-) population, an elevated CD4/CD8 ratio, or restricted V bet
a expression are nor specific to T-cell malignancy and should not be used a
s a sole diagnostic criteria in SS. Entry criteria for future clinical stud
ies will need to be more rigorous if meaningful comparisons are to be made
between different treatment options.